Medicine and Dentistry
Metabolite
100%
Empagliflozin
66%
Urine
55%
Plasma
44%
Hyperglycemia
33%
Insulin Dependent Diabetes Mellitus
33%
Therapeutic Procedure
33%
Citric Acid Cycle
22%
Assessment
22%
Diabetic Nephropathy
11%
Hypoxia
11%
Metabolism
11%
Oxidative Stress
11%
Lipid
11%
Biosynthesis
11%
Aspartic Acid
11%
Sodium Glucose Cotransporter 2 Inhibitor
11%
Alanine
11%
Patient with Type 1 Diabetes
11%
Unsaturated Fatty Acid
11%
Principal Component Analysis
11%
Age
11%
Analysis
11%
Male
11%
Inpatient
11%
Organ
11%
Immunology and Microbiology
Metabolite
100%
Urine
55%
Blood Plasma
44%
Citric Acid Cycle
22%
Oxidative Stress
11%
Metabolism
11%
Biosynthesis
11%
Energy Yield
11%
Age
11%
Organ
11%
Software
11%
Kidney
11%
Pharmacology, Toxicology and Pharmaceutical Science
Empagliflozin
66%
Insulin Dependent Diabetes Mellitus
33%
Hyperglycemia
33%
Aspartic Acid
11%
Lipid
11%
Diabetic Nephropathy
11%
Glutamic Acid
11%
Alanine
11%
Unsaturated Fatty Acid
11%
Sodium Glucose Cotransporter 2 Inhibitor
11%
Hypoxia
11%
Propanoate
11%